AI Article Synopsis
- A 71-year-old man had distal gastrectomy in November 2011 due to well-differentiated adenocarcinoma, classified as pStage IIIA, and received TS-1 as adjuvant therapy for a year.
- In the 16th month post-surgery, CT scans revealed locoregional recurrence near the pancreas and abdominal wall, although no other metastases were detected.
- A pancreaticoduodenectomy and transverse colon merger resection were performed in June 2013, but despite elevated tumor markers afterward, chemotherapy continued to manage complications like obstructive jaundice.
Article Abstract
A 71-year-old man underwent distal gastrectomy for gastric cancer in November 2011. The corresponding pathological diagnosis was of well differentiated adenocarcinoma, pT4a(SE), N1(2/15), H0, P0,M0, pStage IIIA. TS-1 was administered as an adjuvant therapy for one year from the second month after the operation. During the 16th month after the operation, we found an elevated tumor marker level and locoregional recurrence near the pancreas head and the abdominal wall upon computed tomography. We could not find any other suspected tumor recurrence using positron-emission tomography and computed tomography. We performed a pancreaticoduodenectomy and transverse colon merger resection in June 2013. Although the tumor marker was again found to be elevated during the second month after the metastasectomy, chemotherapy was continued because obstructive jaundice and gastrointestinal obstruction were prevented by the operation.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!